Guohui Wan
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 2%
- RNA modifications and cancer
- Cancer-related gene regulation
- RNA Research and Splicing
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 13
- RNA Research and Splicing 7
- RNA Interference and Gene Delivery 4
-
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 8
- Co-authors
- Xiongbin Lu (20 shared papers)Xinna Zhang (14 shared papers)Arabella Wan (17 shared papers)Ziyou Lin (7 shared papers)Yi Niu (6 shared papers)Lei Sun (11 shared papers)Heng Liang (10 shared papers)Xiaoxiao Hu (5 shared papers)
- Journals
- Acta Pharmaceutica Sinica B (3 papers)Nature Communications (3 papers)Journal of Medicinal Chemistry (3 papers)The EMBO Journal (2 papers)Phytotherapy Research (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Guohui Wan
65 papers receiving 3.3k citations
Guohui Wan's Hit Papers
Peers
Comparison fields: 5 of 113
- Cancer Research 1.4k
- Molecular Biology 2.4k
- Oncology 436
- Immunology 197
- Aging 16
Countries citing papers authored by Guohui Wan
This map shows the geographic impact of Guohui Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guohui Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guohui Wan more than expected).
Fields of papers citing papers by Guohui Wan
This network shows the impact of papers produced by Guohui Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guohui Wan. The network helps show where Guohui Wan may publish in the future.
Co-authors
The 25 scholars most cited alongside Guohui Wan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3 Hit paper breakdown → | 2019 | 465 |
| 2 | RNA m6A methylation regulates sorafenib resistance in liver cancer through FOXO3‐mediated autophagy Hit paper breakdown → | 2020 | 368 |
| 3 | 2011 | 184 | |
| 4 | 2015 | 173 | |
| 5 | 2013 | 166 | |
| 6 | 2013 | 150 | |
| 7 | 2010 | 131 | |
| 8 | 2011 | 127 | |
| 9 | 2013 | 112 | |
| 10 | 2016 | 103 | |
| 11 | 2021 | 93 | |
| 12 | 2020 | 87 | |
| 13 | 2014 | 85 | |
| 14 | 2023 | 84 | |
| 15 | 2021 | 71 | |
| 16 | 2018 | 69 | |
| 17 | 2022 | 59 | |
| 18 | 2006 | 52 | |
| 19 | 2013 | 52 | |
| 20 | 2023 | 43 |
About Guohui Wan
Guohui Wan is a scholar working on Molecular Biology, Cancer Research, Oncology, Complementary and alternative medicine and Immunology, having authored 66 papers that have together received 3.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (13 papers), Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (8 papers), RNA Research and Splicing (7 papers), Medicinal Plant Extracts Effects (6 papers), RNA Interference and Gene Delivery (4 papers), Cancer Cells and Metastasis (4 papers) and Tryptophan and brain disorders (4 papers). The work is most often cited by research in Cancer Research (1.4k citations), Molecular Biology (2.4k citations), Oncology (436 citations), Immunology (197 citations) and Aging (16 citations). Guohui Wan has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xiongbin Lu, Xinna Zhang, Arabella Wan, Ziyou Lin, Yi Niu, Lei Sun, Heng Liang, Xiaoxiao Hu, Yunhua Liu and Rohit Mathur. Their work appears in journals such as Acta Pharmaceutica Sinica B, Nature Communications, Journal of Medicinal Chemistry, The EMBO Journal and Phytotherapy Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.